Subject: | PhD studentship available |
---|---|
Date: | Wed, 4 Feb 2015 11:06:16 +0000 |
From: | Steel, Karen <karen.steel@KCL.AC.UK> |
Reply-To: | Steel, Karen <karen.steel@KCL.AC.UK> |
To: | EAR-MAIL@JISCMAIL.AC.UK |
PhD Studentship to study the role of
peroxisome defects in hearing impairment, at the Wolfson
Centre for Age-Related Diseases, Guy’s Campus, King’s
College London
Applications are invited for a PhD
studentship funded by an award from Action on Hearing
Loss, starting in October 2015.
Applicants should have
(or be expected to obtain) a 2:1 or 1st class honours degree
(or overseas equivalent) in a subject relevant to the
proposed project, and should be able to communicate well in
English. The studentship covers course fees (Home/EU rate),
a stipend starting at £17,000 rising each year for three
years in total, and a small contribution towards research
costs, training and conference attendance. Course fees are
available only up to the UK/EU rate, so will not cover the
fees level for students outside the EU. Applicants should
send a full CV, covering letter explaining why you are
applying for this studentship, and contact details of at
least two academic referees to Ms Brenda Williams at
brenda.williams@kcl.ac.uk by the closing date:
24th February 2015. Interviews will be
held during the week beginning 9th March 2015.
For further details of the group’s research,
see
http://www.kcl.ac.uk/ioppn/depts/wolfson/about/people/staff/steelkaren.aspx
or contact Professor Karen P Steel at
karen.steel@kcl.ac.uk. A summary of the project is given below.
Pex3 protein is required for peroxisome genesis
and degradation, and peroxisomes in turn are needed for
metabolic processing of very long chain fatty acids.
PEX3 mutations in humans are known to cause severe
diseases that include hearing impairment, but we know
nothing about the pathological basis of this. This project
involves analysing a new mouse mutation of
Pex3 that has been found by a large-scale screen to
show high frequency hearing impairment. The student will
investigate if the hearing loss is progressive, what
underlying pathological processes occur in the auditory
system, and how peroxisomes and lipids are affected in the
mutant. The mutant allele will be manipulated using Flp and
Cre recombinases to establish whether deafness results from
a local (inner ear) effect or a systemic effect of a lack of
Pex3 activity, and to ask if adult onset of reduced Pex3
activity also leads to hearing impairment. These
experiments will guide future development of therapies for
mild peroxisome defects, which may underlie some forms of
progressive hearing loss due to mild genetic variants or due
to environmental challenges.
Professor Karen P Steel, FMedSci, FRS
Wolfson Centre for Age-Related Diseases,
King's College London, Guy's Campus,
London SE1 1UL
+44 207 848 6203